+
データを開く
-
基本情報
| 登録情報 | データベース: PDB / ID: 5wpl | ||||||
|---|---|---|---|---|---|---|---|
| タイトル | KRas G12V, bound to GppNHp and miniprotein 225-11 | ||||||
要素 |
| ||||||
キーワード | SIGNALING PROTEIN / Inhibitor / Complex | ||||||
| 機能・相同性 | 機能・相同性情報phospholipase C activator activity / GTPase complex / oncogene-induced cell senescence / positive regulation of miRNA metabolic process / T-helper 1 type immune response / positive regulation of ruffle assembly / positive regulation of wound healing / defense response to protozoan / regulation of neurotransmitter receptor localization to postsynaptic specialization membrane / Signaling by RAS GAP mutants ...phospholipase C activator activity / GTPase complex / oncogene-induced cell senescence / positive regulation of miRNA metabolic process / T-helper 1 type immune response / positive regulation of ruffle assembly / positive regulation of wound healing / defense response to protozoan / regulation of neurotransmitter receptor localization to postsynaptic specialization membrane / Signaling by RAS GAP mutants / Signaling by RAS GTPase mutants / Activation of RAS in B cells / RAS signaling downstream of NF1 loss-of-function variants / SOS-mediated signalling / Activated NTRK3 signals through RAS / Activated NTRK2 signals through RAS / adipose tissue development / SHC1 events in ERBB4 signaling / positive regulation of protein targeting to membrane / Signalling to RAS / SHC-related events triggered by IGF1R / Schwann cell development / Activated NTRK2 signals through FRS2 and FRS3 / Estrogen-stimulated signaling through PRKCZ / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / SHC-mediated cascade:FGFR2 / SHC-mediated cascade:FGFR4 / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases / Erythropoietin activates RAS / SHC-mediated cascade:FGFR1 / Signaling by FGFR4 in disease / FRS-mediated FGFR3 signaling / Signaling by FLT3 ITD and TKD mutants / FRS-mediated FGFR2 signaling / FRS-mediated FGFR4 signaling / p38MAPK events / Signaling by FGFR3 in disease / FRS-mediated FGFR1 signaling / protein-membrane adaptor activity / Tie2 Signaling / Signaling by FGFR2 in disease / myelination / EPHB-mediated forward signaling / GRB2 events in EGFR signaling / Signaling by FLT3 fusion proteins / SHC1 events in EGFR signaling / FLT3 Signaling / Signaling by FGFR1 in disease / EGFR Transactivation by Gastrin / NCAM signaling for neurite out-growth / CD209 (DC-SIGN) signaling / Downstream signal transduction / GRB2 events in ERBB2 signaling / Insulin receptor signalling cascade / intrinsic apoptotic signaling pathway / SHC1 events in ERBB2 signaling / Ras activation upon Ca2+ influx through NMDA receptor / Constitutive Signaling by Overexpressed ERBB2 / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / animal organ morphogenesis / positive regulation of epithelial cell proliferation / VEGFR2 mediated cell proliferation / small monomeric GTPase / regulation of actin cytoskeleton organization / FCERI mediated MAPK activation / Signaling by ERBB2 TMD/JMD mutants / Signaling by SCF-KIT / RAF activation / Constitutive Signaling by EGFRvIII / Signaling by high-kinase activity BRAF mutants / Signaling by ERBB2 ECD mutants / cellular response to gamma radiation / MAP2K and MAPK activation / Signaling by ERBB2 KD Mutants / regulation of long-term neuronal synaptic plasticity / positive regulation of JNK cascade / positive regulation of type II interferon production / positive regulation of fibroblast proliferation / chemotaxis / endocytosis / Regulation of RAS by GAPs / Signaling by RAF1 mutants / Negative regulation of MAPK pathway / RAS processing / Signaling by moderate kinase activity BRAF mutants / Paradoxical activation of RAF signaling by kinase inactive BRAF / Signaling downstream of RAS mutants / cellular senescence / Signaling by BRAF and RAF1 fusions / insulin receptor signaling pathway / GDP binding / DAP12 signaling / MAPK cascade / regulation of cell population proliferation / T cell receptor signaling pathway / Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants / RAF/MAP kinase cascade 類似検索 - 分子機能 | ||||||
| 生物種 | Homo sapiens (ヒト)![]() | ||||||
| 手法 | X線回折 / シンクロトロン / 分子置換 / 解像度: 2.15 Å | ||||||
データ登録者 | Lee, S.-J. / Shim, S.Y. / McGee, J.H. / Verdine, G.L. | ||||||
引用 | ジャーナル: J. Biol. Chem. / 年: 2018タイトル: Exceptionally high-affinity Ras binders that remodel its effector domain. 著者: McGee, J.H. / Shim, S.Y. / Lee, S.J. / Swanson, P.K. / Jiang, S.Y. / Durney, M.A. / Verdine, G.L. | ||||||
| 履歴 |
|
-
構造の表示
| 構造ビューア | 分子: Molmil Jmol/JSmol |
|---|
-
ダウンロードとリンク
-
ダウンロード
| PDBx/mmCIF形式 | 5wpl.cif.gz | 197.1 KB | 表示 | PDBx/mmCIF形式 |
|---|---|---|---|---|
| PDB形式 | pdb5wpl.ent.gz | 157.1 KB | 表示 | PDB形式 |
| PDBx/mmJSON形式 | 5wpl.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
| その他 | その他のダウンロード |
-検証レポート
| アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/wp/5wpl ftp://data.pdbj.org/pub/pdb/validation_reports/wp/5wpl | HTTPS FTP |
|---|
-関連構造データ
-
リンク
-
集合体
| 登録構造単位 | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | ![]()
| ||||||||
| 2 | ![]()
| ||||||||
| 3 | ![]()
| ||||||||
| 4 | ![]()
| ||||||||
| 単位格子 |
|
-
要素
-タンパク質 / タンパク質・ペプチド , 2種, 12分子 ADGJBCEFHIKL
| #1: タンパク質 | 分子量: 18960.357 Da / 分子数: 4 / 断片: residues 1-166 / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: HRAS, HRAS1 / 発現宿主: ![]() #2: タンパク質・ペプチド | 分子量: 3796.214 Da / 分子数: 8 / 由来タイプ: 合成 / 由来: (合成) ![]() |
|---|
-非ポリマー , 4種, 245分子 






| #3: 化合物 | ChemComp-GNP / #4: 化合物 | ChemComp-MG / #5: 化合物 | ChemComp-CA / #6: 水 | ChemComp-HOH / | |
|---|
-詳細
| Has protein modification | Y |
|---|
-実験情報
-実験
| 実験 | 手法: X線回折 / 使用した結晶の数: 1 |
|---|
-
試料調製
| 結晶 | マシュー密度: 2.17 Å3/Da / 溶媒含有率: 43.36 % |
|---|---|
| 結晶化 | 温度: 293 K / 手法: 蒸気拡散法, シッティングドロップ法 / 詳細: 0.1 M ammonium sulfate and 20-25% PEG3,350 |
-データ収集
| 回折 | 平均測定温度: 100 K |
|---|---|
| 放射光源 | 由来: シンクロトロン / サイト: APS / ビームライン: 24-ID-C / 波長: 1 Å |
| 検出器 | タイプ: ADSC QUANTUM 315 / 検出器: CCD / 日付: 2013年8月22日 |
| 放射 | プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
| 放射波長 | 波長: 1 Å / 相対比: 1 |
| 反射 | 解像度: 2.15→50 Å / Num. obs: 47914 / % possible obs: 98.1 % / 冗長度: 3.6 % / Net I/σ(I): 12.9 |
-位相決定
| 位相決定 | 手法: 分子置換 |
|---|
-
解析
| ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 精密化 | 構造決定の手法: 分子置換 / 解像度: 2.15→48.14 Å / Cor.coef. Fo:Fc: 0.935 / Cor.coef. Fo:Fc free: 0.895 / SU B: 7.406 / SU ML: 0.185 / 交差検証法: THROUGHOUT / σ(F): 0 / ESU R: 0.31 / ESU R Free: 0.23 詳細: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS U VALUES : REFINED INDIVIDUALLY
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 溶媒の処理 | イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.2 Å | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 原子変位パラメータ | Biso max: 89.75 Å2 / Biso mean: 26.683 Å2 / Biso min: 5.34 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 精密化ステップ | サイクル: final / 解像度: 2.15→48.14 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS精密化 シェル | 解像度: 2.15→2.206 Å / Rfactor Rfree error: 0 / Total num. of bins used: 20
|
ムービー
コントローラー
万見について




Homo sapiens (ヒト)
X線回折
引用















PDBj

























